Navigation Links
BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri

FT. LAUDERDALE, Fla., Aug. 2, 2012 /PRNewswire/ -- BioPower Operations Corporation (OTCQB: BOPO) today announced that its wholly-owned subsidiary FTZ Exchange has executed a Strategic Alliance with Capacity 360, LLC and Founder Tom Settineri to develop excess capacity transactions.

Capacity 360, LLC is a company that assists Global 2000 corporations in developing excess capacity strategies to optimize and monetize their unused, under-utilized manufacturing capacities and assets, while meeting each corporation's strategic goals. Capacity 360's proven business model increases a corporate return on investment by utilizing excess capacity and realizing economies of scale combined with the development of new channels of distribution for the corporation's products, services and assets.

Thomas Settineri, the founder of Capacity 360, LLC, has over 30 years of experience in the establishment and implementation of proven Capacity and Marketing strategies as functional economic responses to a company's need for new business development for their internal and external markets. Mr. Settineri will be exclusive in providing the off-line management, expertise, and initial projects for the Strategic Alliance. The alliance is designed to develop trade disposition programs to unwind, remarket, and sell corporate capacities of unused, and under-utilized manufacturing time, products and services.

Mr. Settineri stated: "There are many benefits for major corporations, including increased credit and improvements in cash flow and working capital, wider market availability, increased sales and more jobs as a result of improved economic activity.  We are excited to bring our initial projects and opportunities to the strategic alliance. I have over 30 years of experience, along with my staff, in doing business with many multi-national corporations. We will offer FTZ a proven network of companies that will bring compelling opportunities and revenues to the Alliance."

Robert Kohn, BioPower Chairman and CEO, stated, "Mr. Settineri and I worked closely together when he was the President of a media purchasing and trading business doing $500 million in annual revenue.  Mr. Settineri's unique capacity business models are excellent methodologies for Global 2000 manufacturers to create jobs and increase profits."

The Alliances initial transactions will be developed off-line.  Our plans are to launch our FTZ Capacity Exchange. 

About BioPower Operations Corporation

FTZ Exchange LLC is a wholly-owned subsidiary of BioPower Operations Corporation and uses its business know-how of on-line and off-line commercial trade strategies to create transaction fee-based internet exchanges to sell products and services to business-to-business and business-to-consumer communities. FTZ currently owns 50% of the QX Health Exchange LLC, with Quture, Inc., a wholly owned subsidiary of Techs Loanstar, Inc. (OTCQB: TCLN).  QX Health Exchange intends to bring quality and competitively priced products and services to the global medical and healthcare marketplace.  The QX Health Exchange intends to establish a B2B and Health Provider to Patient (HP2P) Quality Health Exchange that will serve to connect hospitals/medical facilities; physicians; health workers; insurance providers, medical tourism and patients by providing quality health through valued products, services and technologies at competitive prices.  The QX Health Exchange also intends to sell its own branded health programs and products.

BioPower Operations Corporation is a development stage, reporting company, focused on growing biomass coupled with the production and sale of biomass products and byproducts. The senior management team has analyzed numerous biomass technologies and various market niche opportunities resulting in short term plans to produce and sell biomass oils that can be converted into oils, biofuels, animal feed or electricity.  Biomass is a broad term that encompasses all plant and animal matter that can be used either as a source of energy or for its chemical components when converted into bio oils, biofuels, green electricity, animal feed and other valuable products.

The company's websites can be viewed at and

Forward-Looking Safe Harbor Statement:

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act. The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Those statements include statements regarding the intent, belief or current expectations of BioPower Operations Corporation and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed.


Investor Relations 
Constellation Asset Advisors, Inc.

BioPower Operations Corporation

SOURCE BioPower Operations Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioPower Systems Awarded $5 Million from Victorian Government
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. inVentiv Health Selected to Provide Sales Operations Support for Santarus
4. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
5. StemCyte Adds World Class Talent to its North America and Global Operations
6. Vermillion Sharpens Focus and Streamlines Operations in 2012
7. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
8. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
9. Hospira Names John B. Elliot Senior Vice President of Operations
10. NanoLogix Provides Testing and Operations Update
11. Amarillo Biosciences Announces Plan to Open Asia Operations Center in Taipei, Taiwan
Post Your Comments:
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide ... Carolina , today announced that the company has set a ... a 391% quarter on quarter growth posted for Q3 of 2014 ... and Mexico , with the establishment of ... December 2015. --> United Kingdom and ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier ... models, has promoted Melanie Aregger to serve as Chief Operating Officer. , ... the management team and was promoted to Head of InSphero Diagnostics in ...
Breaking Biology Technology:
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
Breaking Biology News(10 mins):